help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baarends, W. M.
Right arrow Articles by Grootegoed, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baarends, W. M.
Right arrow Articles by Grootegoed, J. A.

Endocrinology, Vol 136, 4951-4962, Copyright © 1995 by Endocrine Society

ARTICLES

Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth

WM Baarends, JT Uilenbroek, P Kramer, JW Hoogerbrugge, EC van Leeuwen, AP Themmen and JA Grootegoed
Department of Endocrinology and Reproduction, Faculty of Medicine and Health Sciences, Erasmus University Rotterdam, The Netherlands.

During fetal development, anti-mullerian hormone (AMH) is produced only by Sertoli cells, but postnatally, granulosa cells also produce this peptide growth/differentiation factor. We recently identified a candidate AMH type II receptor (AMHRII). In the present study, postnatal ovarian AMH and AMHRII messenger RNA (mRNA) expression was studied by in situ hybridization and ribonuclease protection. In ovaries from adult rats, AMH and AMHRII mRNAs were found to be mainly expressed in granulosa cells from preantral and small antral follicles. Corpora lutea and large antral follicles express little or no AMH and AMHRII mRNA, and primordial follicles and oocytes appeared to be AMH and AMHRII mRNA negative. Thecal and interstitial cells express no detectable AMH mRNA and little or no AMHRII mRNA. The colocalization of AMH and AMHRII mRNAs in granulosa cells of specific follicle types suggests that actions of AMH via AMHRII are autocrine in nature. There is a decreased level of AMH and AMHRII mRNA expression when follicles become atretic. Both mRNA species are eventually lost from atretic follicles, although AMHRII mRNA expression seems to persist somewhat longer than AMH mRNA. During the estrous cycle, no marked changes in the patterns of AMH and AMHRII mRNA expression were detected, except at estrus, when expression of both mRNA species in preantral follicles was decreased compared to that on the other days of the cycle. On postnatal day 5, total ovarian AMH mRNA expression is low and is located in small preantral follicles. During the first weeks of postnatal development, AMH mRNA expression in preantral follicles increases, and the later formed small antral follicles also express AMH mRNA. In contrast, AMHRII mRNA is expressed on postnatal day 5 at a higher level than AMH mRNA, but cannot be localized to specific cell types. From postnatal day 15 onward, AMHRII mRNA expression becomes more restricted to the preantral and small antral follicles. Treatment of prepubertal rats with GnRH antagonist (Org 30276) and human recombinant FSH (Org 32489) or with GnRH antagonist and estradiol benzoate resulted in follicle growth and inhibition of AMH and AMHRII mRNA expression in some, but not all, preantral and small antral follicles. These results indicate that FSH and estrogens may play a role in the down-regulation of AMH and AMHRII mRNA expression in vivo when small antral follicles differentiate into large antral follicles. Furthermore, the FSH surge on the morning of estrus may inhibit AMH and AMHRII mRNA expression in preantral follicles.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
 ReproductionHome page
E. W Kabithe and N. J Place
Photoperiod-dependent modulation of anti-Mullerian hormone in female Siberian hamsters, Phodopus sungorus
Reproduction, March 1, 2008; 135(3): 335 - 342.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
P.A Johnson, T.R Kent, M.E Urick, and J.R Giles
Expression and Regulation of Anti-Mullerian Hormone in an Oviparous Species, the Hen
Biol Reprod, January 1, 2008; 78(1): 13 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
F. J Diaz, K. Sugiura, and J. J Eppig
Regulation of Pcsk6 Expression During the Preantral to Antral Follicle Transition in Mice: Opposing Roles of FSH and Oocytes
Biol Reprod, January 1, 2008; 78(1): 176 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Arbo, D.V. Vetori, M.F. Jimenez, F.M. Freitas, N. Lemos, and J.S. Cunha-Filho
Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills
Hum. Reprod., December 1, 2007; 22(12): 3192 - 3196.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. J. Moran, M. Noakes, P. M. Clifton, and R. J. Norman
The Use of Anti-Mullerian Hormone in Predicting Menstrual Response after Weight Loss in Overweight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3796 - 3802.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. M. Nelson, R. W. Yates, and R. Fleming
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy
Hum. Reprod., September 1, 2007; 22(9): 2414 - 2421.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
K. Oktay, M. Sonmezer, O. Oktem, K. Fox, G. Emons, and H. Bang
Absence of Conclusive Evidence for the Safety and Efficacy of Gonadotropin-Releasing Hormone Analogue Treatment in Protecting Against Chemotherapy-Induced Gonadal Injury
Oncologist, September 1, 2007; 12(9): 1055 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S. M El-Naggar, M. T Malik, A. Martin, J. P Moore, M. Proctor, T. Hamid, and S. S Kakar
Development of cystic glandular hyperplasia of the endometrium in Mullerian inhibitory substance type II receptor-pituitary tumor transforming gene transgenic mice
J. Endocrinol., July 1, 2007; 194(1): 179 - 191.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Wachs, M. S. Coffler, P. J. Malcom, and R. J. Chang
Serum Anti-Mullerian Hormone Concentrations Are Not Altered by Acute Administration of Follicle Stimulating Hormone in Polycystic Ovary Syndrome and Normal Women
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1871 - 1874.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Fanchin, D. H. Mendez Lozano, N. Frydman, A. Gougeon, N. di Clemente, R. Frydman, and J. Taieb
Anti-Mullerian Hormone Concentrations in the Follicular Fluid of the Preovulatory Follicle Are Predictive of the Implantation Potential of the Ensuing Embryo Obtained by in Vitro Fertilization
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1796 - 1802.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. A. Visser, A. L. L. Durlinger, I. J. J. Peters, E. R. van den Heuvel, U. M. Rose, P. Kramer, F. H. de Jong, and A. P. N. Themmen
Increased Oocyte Degeneration and Follicular Atresia during the Estrous Cycle in Anti-Mullerian Hormone Null Mice
Endocrinology, May 1, 2007; 148(5): 2301 - 2308.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
F. J. Diaz, K. Wigglesworth, and J. J. Eppig
Oocytes determine cumulus cell lineage in mouse ovarian follicles
J. Cell Sci., April 15, 2007; 120(8): 1330 - 1340.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Rice, K. Ojha, S. Whitehead, and H. Mason
Stage-Specific Expression of Androgen Receptor, Follicle-Stimulating Hormone Receptor, and Anti-Mullerian Hormone Type II Receptor in Single, Isolated, Human Preantral Follicles: Relevance to Polycystic Ovaries
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1034 - 1040.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe
Serum anti-Mullerian hormone throughout the human menstrual cycle
Hum. Reprod., December 1, 2006; 21(12): 3103 - 3107.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. Mazaud Guittot, C. J. Guigon, N. Coudouel, and S. Magre
Consequences of Fetal Irradiation on Follicle Histogenesis and Early Follicle Development in Rat Ovaries
Biol Reprod, November 1, 2006; 75(5): 749 - 759.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Y. Andersen and A. G. Byskov
Estradiol and Regulation of Anti-Mullerian Hormone, Inhibin-A, and Inhibin-B Secretion: Analysis of Small Antral and Preovulatory Human Follicles' Fluid
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4064 - 4069.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.A. Anderson, A.P.N. Themmen, A.A. -Qahtani, N.P. Groome, and D.A. Cameron
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer
Hum. Reprod., October 1, 2006; 21(10): 2583 - 2592.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
D. Modi, D. Bhartiya, and C. Puri
Developmental expression and cellular distribution of Mullerian inhibiting substance in the primate ovary.
Reproduction, September 1, 2006; 132(3): 443 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.B. Carlsson, J.E. Scott, J.A. Visser, O. Ritvos, A.P.N. Themmen, and O. Hovatta
Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Hum. Reprod., September 1, 2006; 21(9): 2223 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. Oktay, O. Oktem, A. Reh, and L. Vahdat
Measuring the Impact of Chemotherapy on Fertility in Women With Breast Cancer
J. Clin. Oncol., August 20, 2006; 24(24): 4044 - 4046.
[Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Q.-a. Yuan, H. H. Simmons, M. K. Robinson, M. Russeva, W. A. Marasco, and G. P. Adams
Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer.
Mol. Cancer Ther., August 1, 2006; 5(8): 2096 - 2105.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-Lechner, and G. Tews
Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles
Hum. Reprod., August 1, 2006; 21(8): 2022 - 2026.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. E. Kevenaar, M. F. Meerasahib, P. Kramer, B. M. N. van de Lang-Born, F. H. de Jong, N. P. Groome, A. P. N. Themmen, and J. A. Visser
Serum Anti-Mullerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice
Endocrinology, July 1, 2006; 147(7): 3228 - 3234.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
E. E Nilsson, C. Detzel, and M. K Skinner
Platelet-derived growth factor modulates the primordial to primary follicle transition.
Reproduction, June 1, 2006; 131(6): 1007 - 1015.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen
Anti-Mullerian hormone: a new marker for ovarian function
Reproduction, January 1, 2006; 131(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, D.B. Seifer, D.L. Keefe, and A.S. Blazar
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology
Hum. Reprod., January 1, 2006; 21(1): 159 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. La Marca, V. De Leo, S. Giulini, R. Orvieto, S. Malmusi, L. Giannella, and A. Volpe
Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause
Reproductive Sciences, October 1, 2005; 12(7): 545 - 548.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. A. Stubbs, K. Hardy, P. Da Silva-Buttkus, J. Stark, L. J. Webber, A. M. Flanagan, A. P. N. Themmen, J. A. Visser, N. P. Groome, and S. Franks
Anti-Mullerian Hormone Protein Expression Is Reduced during the Initial Stages of Follicle Development in Human Polycystic Ovaries
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5536 - 5543.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. J. Guigon, N. Coudouel, S. Mazaud-Guittot, M. G. Forest, and S. Magre
Follicular Cells Acquire Sertoli Cell Characteristics after Oocyte Loss
Endocrinology, July 1, 2005; 146(7): 2992 - 3004.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Eldar-Geva, E. J. Margalioth, M. Gal, A. Ben-Chetrit, N. Algur, E. Zylber-Haran, B. Brooks, M. Huerta, and I. M. Spitz
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism
Hum. Reprod., July 1, 2005; 20(7): 1814 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J. S. Tapanainen
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
Hum. Reprod., July 1, 2005; 20(7): 1820 - 1826.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, S. Giulini, R. Orvieto, V. De Leo, and A. Volpe
Anti-Mullerian hormone concentrations in maternal serum during pregnancy
Hum. Reprod., June 1, 2005; 20(6): 1569 - 1572.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Fanchin, J. Taieb, D. H. M. Lozano, B. Ducot, R. Frydman, and J. Bouyer
High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status
Hum. Reprod., April 1, 2005; 20(4): 923 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Penarrubia, F. Fabregues, D. Manau, M. Creus, G. Casals, R. Casamitjana, F. Carmona, J. A. Vanrell, and J. Balasch
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment
Hum. Reprod., April 1, 2005; 20(4): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Fanchin, D. H. Mendez Lozano, N. Louafi, N. Achour-Frydman, R. Frydman, and J. Taieb
Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation
Hum. Reprod., March 1, 2005; 20(3): 747 - 751.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Jonard, P. Pigny, L. Jacquesson, C. Demerle-Roux, Y. Robert, and D. Dewailly
The ovarian markers of the FSH insufficiency in functional hypothalamic amenorrhoea
Hum. Reprod., January 1, 2005; 20(1): 101 - 107.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. La Marca, S. Malmusi, S. Giulini, L. F. Tamaro, R. Orvieto, P. Levratti, and A. Volpe
Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation
Hum. Reprod., December 1, 2004; 19(12): 2738 - 2741.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. Nikolaou and C. Gilling-Smith
Early ovarian ageing: are women with polycystic ovaries protected?
Hum. Reprod., October 1, 2004; 19(10): 2175 - 2179.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. G.M.G.J. Mulders, J. S.E. Laven, M. J.C. Eijkemans, F. H. de Jong, A. P.N. Themmen, and B. C.J.M. Fauser
Changes in anti-Mullerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility
Hum. Reprod., September 1, 2004; 19(9): 2036 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
C. J. Jorgez, M. Klysik, S. P. Jamin, R. R. Behringer, and M. M. Matzuk
Granulosa Cell-Specific Inactivation of Follistatin Causes Female Fertility Defects
Mol. Endocrinol., April 1, 2004; 18(4): 953 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S. Jonard and D. Dewailly
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
Hum. Reprod. Update, March 1, 2004; 10(2): 107 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Weenen, J. S.E. Laven, A. R.M. von Bergh, M. Cranfield, N. P. Groome, J. A. Visser, P. Kramer, B. C.J.M. Fauser, and A. P.N. Themmen
Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment
Mol. Hum. Reprod., February 1, 2004; 10(2): 77 - 83.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Pigny, E. Merlen, Y. Robert, C. Cortet-Rudelli, C. Decanter, S. Jonard, and D. Dewailly
Elevated Serum Level of Anti-Mullerian Hormone in Patients with Polycystic Ovary Syndrome: Relationship to the Ovarian Follicle Excess and to the Follicular Arrest
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5957 - 5962.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L.E. Bath, W.H.B. Wallace, M.P. Shaw, C. Fitzpatrick, and R.A. Anderson
Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound
Hum. Reprod., November 1, 2003; 18(11): 2368 - 2374.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
A. Balla, N. Danilovich, Y. Yang, and M. R. Sairam
Dynamics of Ovarian Development in the FORKO Immature Mouse: Structural and Functional Implications for Ovarian Reserve
Biol Reprod, October 1, 2003; 69(4): 1281 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Y. Bedecarrats, F. H. O'Neill, E. R. Norwitz, U. B. Kaiser, and J. Teixeira
Regulation of gonadotropin gene expression by Mullerian inhibiting substance
PNAS, August 5, 2003; 100(16): 9348 - 9353.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. C. Connolly, R. Bao, A. Y. Nikitin, K. C. Stephens, T. W. Poole, X. Hua, S. S. Harris, B. C. Vanderhyden, and T. C. Hamilton
Female Mice Chimeric for Expression of the Simian Virus 40 TAg under Control of the MISIIR Promoter Develop Epithelial Ovarian Cancer
Cancer Res., March 15, 2003; 63(6): 1389 - 1397.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Fanchin, L. M. Schonauer, C. Righini, J. Guibourdenche, R. Frydman, and J. Taieb
Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3
Hum. Reprod., February 1, 2003; 18(2): 323 - 327.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Fanchin, L. M. Schonauer, C. Righini, N. Frydman, R. Frydman, and J. Taieb
Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation
Hum. Reprod., February 1, 2003; 18(2): 328 - 332.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Mazaud, C. J. Guigon, A. Lozach, N. Coudouel, M. G. Forest, H. Coffigny, and S. Magre
Establishment of the Reproductive Function and Transient Fertility of Female Rats Lacking Primordial Follicle Stock after Fetal {gamma}-Irradiation
Endocrinology, December 1, 2002; 143(12): 4775 - 4787.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.A.J. van Rooij, F.J.M. Broekmans, E.R. te Velde, B.C.J.M. Fauser, L.F.J.M.M. Bancsi, F.H.d. Jong, and A.P.N. Themmen
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
Hum. Reprod., December 1, 2002; 17(12): 3065 - 3071.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, H. A. Ingraham, M. W. Nachtigal, J. Th. J. Uilenbroek, J. A. Grootegoed, and A. P. N. Themmen
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Endocrinology, March 1, 2002; 143(3): 1076 - 1084.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
Y. Ikeda, A. Nagai, M.-a. Ikeda, and S. Hayashi
Increased Expression of Mullerian-Inhibiting Substance Correlates with Inhibition of Follicular Growth in the Developing Ovary of Rats Treated with E2 Benzoate
Endocrinology, January 1, 2002; 143(1): 304 - 312.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. L. L. Durlinger, M. J. G. Gruijters, P. Kramer, B. Karels, T. R. Kumar, M. M. Matzuk, U. M. Rose, F. H. de Jong, J. Th. J. Uilenbroek, J. A. Grootegoed, et al.
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Endocrinology, November 1, 2001; 142(11): 4891 - 4899.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey
Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 4040 - 4046.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. A. Cushman, J. C. DeSouza, V. S. Hedgpeth, and J. H. Britt
Alteration of Activation, Growth, and Atresia of Bovine Preantral Follicles by Long-Term Treatment of Cows with Estradiol and Recombinant Bovine Somatotropin
Biol Reprod, August 1, 2001; 65(2): 581 - 586.
[Abstract] [Full Text] [PDF]